904 A case report of metastatic castration resistant prostate cancer patient with AR F877L mutation treated with KPG-121 in combination with enzalutamide

• Yao Wang,
• Alfredo Torres,
• Richard Zuniga,
• Chuansheng Ge,
• Baisong Liao

Affiliations

Yao Wang

1State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Hong Kong, China

Alfredo Torres

1New York Cancer and Blood Specialists, New York, NY, USA

Richard Zuniga

1New York Cancer and Blood Specialists, New York, NY, USA

Chuansheng Ge

2Kangpu Biopharmaceuticals, Ltd., Shanghai, China

Baisong Liao

2Kangpu Biopharmaceuticals, Ltd., Shanghai, China